New on Yahoo
Yahoo Finance
Yahoo FinanceThe Fight Against COVID19
23.82k followers • 13 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| The Fight Against COVID19 | +3.86% | - | - | - |
| ^GSPC | +0.07% | +3.25% | +26.36% | +5519.91% |
13 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 150.51 | +0.60 | +0.40% | 12:31 PM EDT | 1.85M | 7.56M | 362.23B |
| ABBV | AbbVie Inc. | 161.43 | +0.68 | +0.42% | 12:31 PM EDT | 990.20k | 5.70M | 285.06B |
| PFE | Pfizer Inc. | 28.31 | +0.30 | +1.07% | 12:31 PM EDT | 16.48M | 42.71M | 160.42B |
| SNY | Sanofi | 49.98 | +0.70 | +1.42% | 12:31 PM EDT | 672.39k | 1.99M | 126.91B |
| REGN | Regeneron Pharmaceuticals, Inc. | 974.12 | +0.32 | +0.03% | 12:27 PM EDT | 91.32k | 455.51k | 107.33B |
| GSK | GSK plc | 45.2342 | +0.16 | +0.36% | 12:31 PM EDT | 1.07M | 3.23M | 92.53B |
| GILD | Gilead Sciences, Inc. | 67.025 | +1.07 | +1.61% | 12:31 PM EDT | 2.22M | 7.18M | 83.50B |
| MRNA | Moderna, Inc. | 123.22 | +5.91 | +5.04% | 12:31 PM EDT | 1.36M | 3.88M | 47.22B |
| TAK | Takeda Pharmaceutical Company Limited | 13.12 | -0.13 | -0.98% | 12:31 PM EDT | 830.35k | 1.67M | 41.28B |
| BNTX | BioNTech SE | 92.585 | +0.92 | +1.00% | 12:28 PM EDT | 85.94k | 600.71k | 22.31B |
| NVAX | Novavax, Inc. | 12.7 | +3.82 | +43.02% | 12:31 PM EDT | 84.29M | 9.46M | 1.78B |
| VIR | Vir Biotechnology, Inc. | 9.79 | +0.35 | +3.71% | 12:30 PM EDT | 282.07k | 1.02M | 1.33B |
| INO | Inovio Pharmaceuticals, Inc. | 11.5 | +0.85 | +7.98% | 12:30 PM EDT | 172.96k | 443.32k | 297.93M |
- Yahoo Finance Video
Johnson & Johnson to sell remaining stake in Kenvue
Shares of Kenvue (KVUE) are trading slightly higher on Monday after Johnson & Johnson (JNJ) announced it would sell its remaining 9.5% stake in the company. Kenvue will not receive any money from the sale. Yahoo Finance Anchors Seana Smith and Jared Blikre break down the latest developments for these companies. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Nicholas Jacobino
Insider Monkey12 Undervalued Stocks That Just Raised Their Dividends
In this article, we discuss 12 best dividend stocks that are undervalued and have just raised their payouts. You can skip our detailed analysis of dividend and value stocks and their previous performance, and go directly to read 5 Undervalued Stocks That Just Raised Their Dividends. Dividend stocks didn’t perform well in 2023. However, this […]
Pharmaceutical TechnologyTakeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
Takeda will pay $100m upfront and up to $2.1bn in milestone-based payments for licensing AC immune’s amyloid beta-targeting immunotherapy.